AMGEN INC (AMGN) Nonoperating Income (Expense) USD 2010 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary: Amgen Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2024.
Amgen Inc Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$235 M, a 111% decline year-over-year.
Amgen Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $534 M, a 70% decline year-over-year.
Amgen Inc annual Nonoperating Income (Expense) for 2023 was $2.83 B.
Amgen Inc annual Nonoperating Income (Expense) for 2022 was -$814 M, a 414% decline from 2021.
Amgen Inc annual Nonoperating Income (Expense) for 2021 was $259 M, a 1.17% increase from 2020.

Nonoperating Income (Expense), Trailing 12 Months (USD)

Nonoperating Income (Expense), Quarterly Data (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$534 M	-$235 M	-$2.3 B	-111%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-03
Q4 2023	$2.83 B	$402 M	+$469 M		Oct 1, 2023	Dec 31, 2023	10-K	2024-02-14
Q3 2023	$2.36 B	$685 M	+$585 M	+585%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-10-31
Q2 2023	$1.78 B	-$318 M	-$1 M	-0.32%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-04
Q1 2023	$1.78 B	$2.06 B	+$2.59 B		Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-03
Q4 2022	-$814 M	-$67 M	-$229 M	-141%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-14
Q3 2022	-$585 M	$100 M	+$27 M	+37%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-31
Q2 2022	-$612 M	-$317 M	-$328 M	-2982%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-04
Q1 2022	-$284 M	-$530 M	-$543 M	-4177%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-28
Q4 2021	$259 M	$162 M	-$25 M	-13.4%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-14
Q3 2021	$284 M	$73 M	+$18 M	+32.7%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-04
Q2 2021	$266 M	$11 M	+$8 M	+267%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-05
Q1 2021	$258 M	$13 M	+$2 M	+18.2%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-28
Q4 2020	$256 M	$187 M	-$49 M	-20.8%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-09
Q3 2020	$305 M	$55 M	-$59 M	-51.8%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	$364 M	$3 M	-$215 M	-98.6%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	$579 M	$11 M	-$174 M	-94.1%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-28
Q4 2019	$753 M	$236 M	+$81 M	+52.3%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-16
Q3 2019	$672 M	$114 M	-$12 M	-9.52%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-29
Q2 2019	$684 M	$218 M	+$56 M	+34.6%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-29
Q1 2019	$628 M	$185 M	-$46 M	-19.9%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-01
Q4 2018	$674 M	$155 M	-$146 M	-48.5%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-09
Q3 2018	$820 M	$126 M	-$141 M	-52.8%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-30
Q2 2018	$961 M	$162 M	-$3 M	-1.82%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-31
Q1 2018	$964 M	$231 M	+$36 M	+18.5%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-01
Q4 2017	$928 M	$301 M	+$175 M	+139%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-12
Q3 2017	$753 M	$267 M	+$51 M	+23.6%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-31
Q2 2017	$702 M	$165 M	+$28 M	+20.4%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-07-27
Q1 2017	$674 M	$195 M	+$45 M	+30%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-04-25
Q4 2016	$629 M	$126 M	-$38 M	-23.2%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-13
Q3 2016	$667 M	$216 M	+$81 M	+60%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-26
Q2 2016	$586 M	$137 M	-$61 M	-30.8%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-07-26
Q1 2016	$647 M	$150 M	+$44 M	+41.5%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-04-27
Q4 2015	$603 M	$164 M	+$76 M	+86.4%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-13
Q3 2015	$527 M	$135 M	-$5 M	-3.57%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-10-28
Q2 2015	$532 M	$198 M	+$60 M	+43.5%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-07-29
Q1 2015	$472 M	$106 M	+$7 M	+7.07%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-02
Q4 2014	$465 M	$88 M	$0	0%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-14
Q3 2014	$465 M	$140 M	+$68 M	+94.4%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-02
Q2 2014	$397 M	$138 M	+$42 M	+43.8%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-05
Q1 2014	$355 M	$99 M	-$65 M	-39.6%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-04-27
Q4 2013	$420 M	$88 M	-$38 M	-30.2%	Oct 1, 2013	Dec 31, 2013	8-K	2016-10-31
Q3 2013	$458 M	$72 M	-$39 M	-35.1%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-10-29
Q2 2013	$497 M	$96 M	-$28 M	-22.6%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-05
Q1 2013	$525 M	$164 M	+$40 M	+32.3%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-04-30
Q4 2012	$485 M	$126 M	+$42 M	+50%	Oct 1, 2012	Dec 31, 2012	10-K	2015-02-19
Q3 2012	$443 M	$111 M	+$24 M	+27.6%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-10-29
Q2 2012	$419 M	$124 M	-$5 M	-3.88%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-06
Q1 2012	$424 M	$124 M	-$24 M	-16.2%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-03
Q4 2011	$448 M	$84 M	-$9 M	-9.68%	Oct 1, 2011	Dec 31, 2011	10-K	2014-02-24
Q3 2011	$457 M	$87 M	-$18 M	-17.1%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-06
Q2 2011	$475 M	$129 M	+$35 M	+37.2%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-08
Q1 2011	$440 M	$148 M	+$64 M	+76.2%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-08
Q4 2010	$376 M	$93 M			Oct 1, 2010	Dec 31, 2010	10-K	2013-02-27
Q3 2010		$105 M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-04
Q2 2010		$94 M			Apr 1, 2010	Jun 30, 2010	10-Q	2011-08-08
Q1 2010		$84 M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.